Alvotech ALVO
NASDAQ ALVO
$4.05 +0.06 (+1.38%)
At close: Aug 20, 2026 · 11:01 AM UTC

Alvotech (ALVO) Interest & Investment Income (2021 - 2026)

Alvotech's (ALVO) quarterly Interest & Investment Income came in at $33.4 million in Q1 2026, down 73.55% YoY from $126.3 million in Q1 2025, and up 20.17% on a QoQ basis from $27.8 million in Q4 2025.

Alvotech (ALVO) Interest & Investment Income (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has 6 years of Interest & Investment Income data on file, last reported at $33.4 million in Q1 2026.

  • Quarterly Interest & Investment Income fell 73.55% year-over-year to $33.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.6 million (down 48.85% YoY) and the FY2025 annual result came in at $198.5 million, up 147.67% from the prior year.
  • Interest & Investment Income improved to $33.4 million in Q1 2026, from $27.8 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $126.3 million in Q1 2025 to a low of -$41.6 million in Q4 2023.
  • A 5-year average of $39.3 million and a median of $27.8 million in 2025 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2023 — Interest & Investment Income tumbled 181.54% — and 2025, when it soared 16131189.91%.
  • Tracing ALVO's Interest & Investment Income over 5 years: stood at $51.0 million in 2022, then plunged by 181.54% to -$41.6 million in 2023, then soared by 102.56% to $1.1 million in 2024, then soared by 2508.35% to $27.8 million in 2025, then grew by 20.17% to $33.4 million in 2026.
  • The last three Interest & Investment Income figures came in at $33.4 million (Q1 2026), $27.8 million (Q4 2025), and $21.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Haleon 43.81 Bn 42.84 Bn - -
2 Teva Pharmaceutical Industries 43.29 Bn 39.63 Bn 2.15 Bn -
3 Zoetis 31.59 Bn 29.91 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.67 Bn 22.88 Bn 5.10 Bn 154.39 Mn
5 United Therapeutics 22.24 Bn 19.58 Bn 683.80 Mn 31.50 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.71 Bn 15.32 Bn 935.80 Mn 12.40 Mn
8 Elanco Animal Health 12.09 Bn 11.56 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alvotech 1.18 Bn 1.18 Bn 5.09 Mn 33.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.41 Mn
Dec 31, 2025 27.81 Mn
Sep 30, 2025 21.44 Mn
Jun 30, 2025 22.94 Mn
Mar 31, 2025 126.31 Mn
Dec 31, 2024 1.07 Mn
Sep 30, 2024 -1.74 Mn
Jun 30, 2024 80.82 Mn
Mar 31, 2024 783.00
Dec 31, 2023 -41.56 Mn
Aug 31, 2023 122.48 Mn
Jun 30, 2023 122.48 Mn
Mar 31, 2023 1,226.00
Dec 31, 2022 50.97 Mn
Aug 31, 2022 50.97 Mn
Jun 30, 2022 50.96 Mn
Mar 31, 2022 4,000.00
Dec 31, 2021 51.56 Mn
Sep 30, 2021 3,000.00